Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction
Objectives. Low survival rate of mesenchymal stem cells (MSCs) severely limited the therapeutic efficacy of cell therapy in the treatment of myocardial infarction (MI). Bcl-xL genetic modification might enhance MSC survival after transplantation. Methods. Adult rat bone marrow MSCs were modified wit...
Saved in:
| Main Authors: | Xiaodong Xue, Yu Liu, Jian Zhang, Tao Liu, Zhonglu Yang, Huishan Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2015/176409 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
by: Atenea A. Perez-Serna, et al.
Published: (2025-01-01) -
Bax mitochondrial relocation is linked to its phosphorylation and its interaction with Bcl-xL
by: David Garenne, et al.
Published: (2016-12-01) -
Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells.
by: Maria Teresa Vento, et al.
Published: (2010-12-01) -
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition
by: Trang Thi Thu Nguyen, et al.
Published: (2019-08-01) -
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
by: Song Han, et al.
Published: (2025-01-01)